Cervel Neurotech Scores $11 Million For Device-Based Depression Therapy

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medical maker Cervel Neurotech is nearing the close of an $11.9 million fundraising round in support of its technology-based treatment for mental illness. California-based medical device maker Cervel Neurotech is nearing the close of an $11.9 million funding round, having raised $11.1 million since April 2013 in support of its technology-based therapies for neurological and psychiatric disorders. The company filed an amendment this month citing 8 unnamed investors participating in its financing round, which involved sales of equity, rights and securities.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC